Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
This study has been completed.
Information provided by (Responsible Party):
National Institute of Mental Health (NIMH)
First received: January 17, 2000
Last updated: February 26, 2015
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||August 2013|
|Primary Completion Date:||August 2013 (Final data collection date for primary outcome measure)|